Cargando…
Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
BACKGROUND: Diverse research approaches support the concept that a clinical diagnosis of Late-Onset Alzheimer's Disease (LOAD) does not distinguish between subpopulations with differing neuropathologies, including dementia patients with amyloid deposition and dementia patients without amyloid d...
Autores principales: | Wood, Paul L., Locke, Victoria A., Herling, Patrick, Passaro, Angelina, Vigna, Giovanni B., Volpato, Stefano, Valacchi, Giuseppe, Cervellati, Carlo, Zuliani, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802395/ https://www.ncbi.nlm.nih.gov/pubmed/27051586 http://dx.doi.org/10.1016/j.bbacli.2015.11.004 |
Ejemplares similares
-
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease
por: Zuliani, Giovanni, et al.
Publicado: (2020) -
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease
por: Zuliani, Giovanni, et al.
Publicado: (2018) -
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018) -
BACE1 role in Alzheimer's disease and other dementias: from the theory to the practice
por: Cervellati, Carlo, et al.
Publicado: (2021) -
Early elevation of BACE1 in dementia
por: Cervellati, Carlo, et al.
Publicado: (2021)